Wordt geladen...
Bcr-Abl tyrosine kinase inhibitors- current status
Bcr-Abl plays a central role in the development of chromosome positive leukaemia. Chronic Myeloid leukaemia occurs due to increase proliferation and resistance to apoptosis by Bcr-Abl positive cells. Imatinib (STI571) is the first drug in the family of Bcr-Abl tyrosine kinase inhibitors while Niloti...
Bewaard in:
| Hoofdauteurs: | , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3706229/ https://ncbi.nlm.nih.gov/pubmed/23787070 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1750-9378-8-23 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|